To Explore the Stem Cells Homing to GBM: The Rise to the Occasion
Multiple efforts are currently underway to develop targeted therapeutic deliveries to the site of glioblastoma progression. The use of carriers represents advancement in the delivery of various therapeutic agents as a new approach in neuro-oncology. Mesenchymal stem cells (MSCs) and neural stem cells (NSCs) are used because of their capability in migrating and delivering therapeutic payloads to tumors. Two of the main properties that carrier cells should possess are their ability to specifically migrate from the bloodstream and low immunogenicity. In this article, we also compared the morphological and molecular features of each type of stem cell that underlie their migration capacity to glioblastoma. Thus, the major focus of the current review is on proteins and lipid molecules that are released by GBM to attract stem cells.
Top-30
Journals
|
1
|
|
|
International Journal of Molecular Sciences
1 publication, 11.11%
|
|
|
JCI insight
1 publication, 11.11%
|
|
|
Tissue and Cell
1 publication, 11.11%
|
|
|
IUBMB Life
1 publication, 11.11%
|
|
|
Current Stem Cell Research and Therapy
1 publication, 11.11%
|
|
|
Phytomedicine
1 publication, 11.11%
|
|
|
International Journal of Emergency Medicine
1 publication, 11.11%
|
|
|
Cancer Management and Research
1 publication, 11.11%
|
|
|
Stem Cell Reviews and Reports
1 publication, 11.11%
|
|
|
1
|
Publishers
|
1
2
|
|
|
Elsevier
2 publications, 22.22%
|
|
|
Springer Nature
2 publications, 22.22%
|
|
|
MDPI
1 publication, 11.11%
|
|
|
American Society for Clinical Investigation
1 publication, 11.11%
|
|
|
Wiley
1 publication, 11.11%
|
|
|
Bentham Science Publishers Ltd.
1 publication, 11.11%
|
|
|
Taylor & Francis
1 publication, 11.11%
|
|
|
1
2
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.